Global Health

Global Health Book Value per Share

The Book Value per Share of Global Health (MEDANTA.NS) as of Nov 10, 2026 is 147.49 INR. In the previous year, Book Value per Share was 126.07 INR — a change of 16.98% (higher).

Book Value per Share

147.49INR

YoY

16.98%

Last updated:

Book Value per Share of Global Health is 2026 147.49 INR. Book Value per Share of Global Health was 2025 126.07 INR. It decreases by 16.98% higher compared to the previous year.

The Global Health Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2019
48.23 INR
Jan 1, 2020
50.24 INR
Jan 1, 2021
51.46 INR
Jan 1, 2022
60.16 INR
Jan 1, 2023
90.40 INR
Jan 1, 2024
108.17 INR
Jan 1, 2025
126.07 INR
Jan 1, 2026
147.49 INR
The Global Health Book Value per Share history
YEARBook Value per ShareYoY
147.49INR+16.98%
126.07INR+16.55%
108.17INR+19.66%
90.40INR+50.26%
60.16INR+16.90%
51.46INR+2.43%
50.24INR+4.17%
48.23INR+6.43%
45.32INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Global Health Stock analysis

What does Global Health do? Global Health Ltd. provides healthcare, pathology, and medical services through its Medanta brand, operating five hospitals in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow, alongside six Mediclinic diagnostic laboratories. The company generates revenue by delivering treatments for conditions such as coronary artery disease, head and neck cancer, acute myeloid leukemia, and chronic kidney disease, alongside specialized services in cardiac surgery, nephrology, urology, and interventional cardiology. Its offerings include medicine delivery, lab tests & diagnostics, homecare, and telemedicine, targeting patients seeking advanced medical care across multiple specialties. Medanta serves urban and semi-urban segments in India, focusing on high-demand treatments and comprehensive healthcare solutions. The company monetizes through direct patient services at its hospitals and diagnostic centers, with revenue derived from procedures, consultations, and diagnostic tests. Treatments for chronic conditions like diabetes, hypertension, and bronchial asthma, as well as acute cases such as cerebral stroke and sepsis, form a significant portion of its service portfolio. Patients utilize Medanta’s telemedicine and homecare services for convenience, while its diagnostic labs provide lab tests & diagnostics to both in-person and remote clients. Revenue streams are driven by high-volume treatments and specialized medical expertise across its network of facilities. Medanta’s service mix includes cardiology, oncology, neurology, and orthopedics, with a focus on conditions like Parkinson’s disease, prostate cancer, and rheumatoid arthritis. The company’s revenue model relies on comprehensive care packages, including hospital stays, outpatient visits, and follow-up services. Its facilities in Delhi, Gurugram, and other cities cater to both private and government-affiliated patients, though the business description does not specify government contracts. The company’s diagnostic laboratories and telemedicine services expand its reach, enabling revenue from multiple touchpoints within the healthcare ecosystem. Global Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Global Health stock

Book Value per Share of Global Health is 147.49 INR in 2026.

Book Value per Share of Global Health changed from 126.07 INR to 147.49 INR, representing a 16.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Global Health since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Global Health

All Key Metrics — Global Health